The Association of Southeast Asian Nations (ASEAN), which is comprised of the countries Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Brunei, Laos, Myanmar, and Cambodia, was established in 1967 to promote peace and stability in the region, facilitate collaboration and mutual assistance among the... Read More
Starting in October 2018, the Korean Ministry of Food and Drug Safety (MFDS) will implement stronger controls on clinical trials done in Korea. Going forward, medical institutions will need to provide more information on possible side effects of a clinical trial. In... Read More
Eager to hasten the availability of medicines for rare diseases and life-threatening illnesses to Chinese consumers, China is easing approval procedures for orphan drug imports. At a meeting this summer, the China State Council set a review timeline of just three months... Read More
Continuing to refine its system for registering medical devices, Hong Kong’s Medical Device Control Office is encouraging importers to adhere to new rules designed to improve quality control for consumers and decrease uncertainty for manufacturers. In accordance with the new procedures, which... Read More
Moving to implement a series of first-time regulations on its growing medical device industry, the Indian government has announced that ultrasounds and other imaging devices sold in the country will soon require registration. The recent announcement by India’s Central Drugs Standard Control... Read More
This article was originally published on MedTech Intelligence. More and more Chinese investment companies are putting their money into Western medtech companies these days. Just recently, Grail, Inc., a California-based early cancer detection company, secured a $300 million Series C funding round... Read More
A Malaysian law requiring companies that manufacture or market medical devices in the country to register with the government goes into full effect this month, six years after it was first passed. The 2012 law was designed to bring Malaysia, which imports... Read More
Beginning November 1, 2018, high-risk medicines sold in India will be required to carry warnings on the packaging, part of a series of moves by the country’s Ministry of Health and Family Welfare to toughen labeling norms on pharmaceuticals. Under the new... Read More
In a step forward for the advancement of health research in South Korea, patients participating in clinical trials aimed at advancing public health are now covered by the country’s vaunted national health insurance system. The change went into effect on May 1.... Read More
Starting June 1, Singapore no longer requires certain low risk medical devices, such as sterile medical examination gloves and intravenous sets, to be registered with the government before they are offered for sale. The change announced by Singapore’s Health Sciences Authority, the... Read More